ASHLEIGH TALERICO: Open Payments
NPI 1376094219 · NEW MIDDLETOWN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$703 in 50 payments from 11 companies in 2025. Trend: 2023 $1,310 · 2024 $980 · 2025 $703
Food & beverage: $703
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 14 | $178 |
| ABBVIE INC. | 17 | $170 |
| Axsome Therapeutics, Inc. | 4 | $89 |
| Lundbeck LLC | 4 | $65 |
| E.R. Squibb & Sons, L.L.C. | 3 | $52 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
| Janssen Pharmaceuticals, Inc | 2 | $30 |
| Collegium Pharmaceutical, Inc. | 1 | $24 |
| Corium, LLC | 1 | $22 |
| Tris Pharma Inc | 1 | $20 |
Products named: VRAYLAR, ABILIFY MAINTENA, Auvelity, REXULTI, COBENFY, CAPLYTA, SPRAVATO, ABILIFY ASIMTUFII.
Industry payments across OH — which companies pay providers there.
